Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia

Journal of Investigative Dermatology

Volumn 126, Issue 4, 2006, Pages 869-881

  Haider, Asifa S ^a   Peters, Sara B ^b   Kaporis, Helen ^a   Cardinale, Irma ^a   Fei, Ji ^a   Ott, Jurg ^a   Blumenberg, Miki ^c   Bowcock, Ann M ^d   Krueger, James G ^a   Carucci, John A ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CATHEPSIN L; CD8 ANTIGEN; CD83 ANTIGEN; COLLAGENASE 3; CYSTATIN; CYTOKERATIN 16; DEFENSIN; GRANZYME B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MICROSEMINOPROTEIN BETA; PLEIOTROPHIN; PROTEIN; SERINE PROTEINASE INHIBITOR; STAT1 PROTEIN; STAT3 PROTEIN; STROMELYSIN 2; UNCLASSIFIED DRUG; WNT 5A PROTEIN; WNT PROTEIN; WNT RECEPTOR FRIZZLED HOMOLOG 6;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL HYPERPLASIA; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALIGNANT NEOPLASTIC DISEASE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOMICS; HUMANS; HYPERPLASIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN NEOPLASMS;

EID: 33645026707     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700157     Document Type: Article

References (61)

1. Ahmed MI, Salahy EE, Tawfiq H, Khalifa A, Hassan MM (2004) Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: relationship with prognosis. Dis Markers 20:333-43
2. Ala-aho R, Crenman R, Seth P, Kahari VM (2002) Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene 21:1187-95
3. An KP, Athar M, Tang X, Katiyar SK, Russo J, Beech J et al. (2002) Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol 76:73-80
4. Aznavoorian S, Moore BA, Alexander-Lister LD, Hallit SL, Windsor LJ, Engler JA (2001) Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Cancer Res 61:6264-75
5. Banno T, Gazel A, Blumenberg M (2004) Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279:32633-42
6. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K et al. (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 10:1793-805
7. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ (1996) Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1:136-42
8. Carucci JA, Martinez JC, Zeitouni NC, Christenson L, Coldiron B, Zweibel S et al. (2004) In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 30(4 part 2):651-5
9. Chan KS, Carbajal S, Kiguchi K, Clifford J, Sano S, DiGiovanni J (2004) Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res 64:2382-9
10. De Pita O, Frezzolini A, Cianetti A, De Sanctis G, Fontana L, Bottari V (1999) Squamous cell carcinoma-related antigen (SCCr-Ag), sICAM-1 and beta 2-microglobulin are useful markers of disease activity in psoriasis. Acta Derm Venereol 79:132-5
11. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY (2002) Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys 397:162-71
12. Frigola J, Munoz M, Clark SJ, Moreno V, Capella G, Peinado MA (2005) Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy. Oncogene
13. Gabril MY, Duan W, Wu G, Moussa M, Izawa JI, Panchal CJ et al. (2005) A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. Mol Ther 11:348-62
14. Gee JR, Montoya RG, Khaled HM, Sabichi AL, Grossman HB (2003) Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder. Urol Oncol 21:266-70
15. Ginos MA, Page GP, Michalowicz BS, Patel KJ, Volker SE, Pambuccian SE et al. (2004) Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64:55-63
16. Golan T, Yaniv A, Bafico A, Liu G, Gazit A (2004) The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade. J Biol Chem 279:14879-88
17. Goldman GD (1998) Squamous cell cancer: a practical approach. Semin Cutan Med Surg 17:80-95
18. Green CL, Khavari PA (2004) Targets for molecular therapy of skin cancer. Semin Cancer Biol 14:63-9
19. Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H et al. (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202:14-22
20. Keith RL, Miller YE, Hudish TM, Girod CE, Sotto-Santiago S, Franklin WA et al. (2004) Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice. Cancer Res 64:5897-904
21. Kerkela E, Saarialho-Kere U (2003) Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. Exp Dermatol 12:109-25
22. Kerkela E, Ala-aho R, Klemi P, Grenman S, Shapiro SD, Kahari VM et al. (2002) Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198:258-69
23. Kubo Y, Murao K, Matsumoto K, Arase S (2002) Molecular carcinogenesis of squamous cell carcinomas of the skin. J Med Invest 49:111-7
24. Leffell DJ, Brash DE (1996) Sunlight and skin cancer. Sci Am 275:52-3, 56-9
25. Leversha MA, Fielding P, Watson S, Gosney JR, Field JK (2003) Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol 200:610-9
26. Lew W, Lee E, Krueger JG (2004) Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris. Br J Dermatol 150:668-76
27. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781-810
28. Lowes MA, Lew W, Krueger JG (2004) Current concepts in the immunopathogenesis of psoriasis. Dermatol Clin 22:349-69, vii
29. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G et al. (2001) Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 91:288-94
30. Lyons JP, Mueller UW, Ji H, Everett C, Fang X, Hsieh JC et al. (2004) Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res 298:369-87
31. Macabeo-Ong M, Shiboski CH, Silverman S, Ginzinger DG, Dekker N, Wong DT et al. (2003) Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression. Oral Oncol 39:638-47
32. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I et al. (2004) Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64:4717-20
33. McLellan AD, Starling GC, Williams LA, Hock BD, Hart DN (1995) Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. Eur J Immunol 25:2064-8
34. Nagavarapu U, Relloma K, Herron GS (2002) Membrane type 1 matrix metalloproteinase regulates cellular invasiveness and survival in cutaneous epidermal cells. J Invest Dermatol 118:573-81
35. Nguyen TH (2004) Mechanisms of metastasis. Clin Dermatol 22:209-16
36. Nomura T, Katunuma N (2005) Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 52:1-9
37. O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B et al. (2005) Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24:1244-51
38. O'Grady A, O'Kelly P, Murphy GM, Leader M, Kay E (2004) COX-2 expression correlates with microvessel density in non-melanoma skin cancer from renal transplant recipients and immunocompetent individuals. Hum Pathol 35:1549-55
39. Pardo J, Balkow S, Anel A, Simon MM (2002) Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol 32:2881-7
40. Pedranzini L, Leitch A, Bromberg J (2004) Stat3 is required for the development of skin cancer. J Clin Invest 114:619-22
41. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S et al. (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98:3156-61
42. Pentland AP, Schoggins JW, Scott GA, Khan KN, Han R (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20:1939-44
43. Quadros MR, Peruzzi F, Kari C, Rodeck U (2004) Complex regulation of signal transducers and activators of transcription 3 activation in normal and malignant keratinocytes. Cancer Res 64:3934-9
44. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC (2002) p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 29:517-23
45. Rowe DE, Carroll RJ, Day CL Jr (1992) Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 26:976-90
46. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K et al. (2005a) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9
47. Sano S, Chan KS, Kira M, Kataoka K, Takagi S, Tarutani M et al. (2005b) Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 65:5720-9
48. Takeda A, Kajiya A, Iwasawa A, Nakamura Y, Hibino T (2002) Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis. Biol Chem 383:1231-6
49. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M (2003) Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 94:593-7
50. Terao H, Nakayama J, Urabe A, Hori Y (1992) Immunohistochemical characterization of cellular infiltrates in squamous cell carcinoma and Bowen's disease occurring in one patient. J Dermatol 19:408-13
51. Tsai KY, Tsao H (2004) The genetics of skin cancer. Am J Med Genet C 131C:82-92
52. Van Themsche C, Alain T, Kossakowska AE, Urbanski S, Potworowski EF, St-Pierre Y (2004) Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol 173:3605-11
53. Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG et al. (1999) Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 85:1758-64
54. Vitale-Cross L, Amornphimoltham P, Fisher G, Molinolo AA, Gutkind JS (2004) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 64:8804-7
55. Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM (2003) Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinogen 38:49-58
56. Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88
57. Wu H, Barusevicius A, Babb J, Klein-Szanto A, Godwin A, Elenitsas R et al. (2005) Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J Cutan Pathol 32:125-30
58. Yan M, Rerko RM, Platzer P, Dawson D, Willis J, Tong M et al. (2004) 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers. Proc Natl Acad Sci USA 101:17468-73
59. Yang F, Zeng Q, Yu G, Li S, Wang CY (2005) Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal
60. Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L et al. (2004) Cystatin m: a novel candidate tumor suppressor gene for breast cancer. Cancer Res 64:6957-64
61. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A et al. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78